Pancreatic cancer can be treated, but it is rarely curable and often fatal. Pancreatic tumors are either exocrine or neuroendocrine ... vomiting, rashes, and lowered blood cell counts.

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Cabometyx is approved for treating well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 years and older ... They can cause painful rash in the hands and feet, ...

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Steve Jobs had what is called a neuroendocrine pancreatic tumor, a type that accounts for fewer than 5% of pancreatic cancers and, experts say, differs substantially from the more common kind.

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs.